-
Something wrong with this record ?
Plant coumestans: recent advances and future perspectives in cancer therapy
T. Nehybová, J. Šmarda, P. Beneš,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
Grant support
NT13441
MZ0
CEP Register
- MeSH
- Anticarcinogenic Agents chemistry metabolism therapeutic use MeSH
- Phytoestrogens metabolism MeSH
- Antineoplastic Agents, Phytogenic chemistry metabolism therapeutic use MeSH
- Coumarins chemistry metabolism therapeutic use MeSH
- Humans MeSH
- Neoplasms drug therapy prevention & control MeSH
- Plants chemistry metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Natural products are often used in drug development due to their ability to form unique and diverse chemical structures. Coumestans are polycyclic aromatic plant secondary metabolites containing a coumestan moiety, which consists of a benzoxole fused to a chromen-2-one to form 1-Benzoxolo[3,2-c]chromen-6-one. These natural compounds are known for large number of biological activities. Many of their biological effects can be attributed to their action as phytoestrogens and polyphenols. In the last decade, anticancer effects of these compounds have been described in vitro but there is only limited number of studies based on models in vivo. More information concerning their in vivo bioavailability, stability, metabolism, toxicity, estrogenicity, cellular targets and drug interactions is therefore needed to proceed further to clinical studies. This review focuses on coumestans exhibiting anticancer properties and summarizes mechanisms of their toxicity to cancer cells. Moreover, the possible role of coumestans in cancer prevention is discussed.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031962
- 003
- CZ-PrNML
- 005
- 20181114095209.0
- 007
- ta
- 008
- 151005s2014 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/1871520614666140713172949 $2 doi
- 035 __
- $a (PubMed)25019627
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Nehybová, Tereza
- 245 10
- $a Plant coumestans: recent advances and future perspectives in cancer therapy / $c T. Nehybová, J. Šmarda, P. Beneš,
- 520 9_
- $a Natural products are often used in drug development due to their ability to form unique and diverse chemical structures. Coumestans are polycyclic aromatic plant secondary metabolites containing a coumestan moiety, which consists of a benzoxole fused to a chromen-2-one to form 1-Benzoxolo[3,2-c]chromen-6-one. These natural compounds are known for large number of biological activities. Many of their biological effects can be attributed to their action as phytoestrogens and polyphenols. In the last decade, anticancer effects of these compounds have been described in vitro but there is only limited number of studies based on models in vivo. More information concerning their in vivo bioavailability, stability, metabolism, toxicity, estrogenicity, cellular targets and drug interactions is therefore needed to proceed further to clinical studies. This review focuses on coumestans exhibiting anticancer properties and summarizes mechanisms of their toxicity to cancer cells. Moreover, the possible role of coumestans in cancer prevention is discussed.
- 650 _2
- $a antikarcinogenní látky $x chemie $x metabolismus $x terapeutické užití $7 D016588
- 650 _2
- $a fytogenní protinádorové látky $x chemie $x metabolismus $x terapeutické užití $7 D000972
- 650 _2
- $a kumariny $x chemie $x metabolismus $x terapeutické užití $7 D003374
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory $x farmakoterapie $x prevence a kontrola $7 D009369
- 650 _2
- $a fytoestrogeny $x metabolismus $7 D048789
- 650 _2
- $a rostliny $x chemie $x metabolismus $7 D010944
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Šmarda, Jan, $d 1961- $7 mzk2006343362
- 700 1_
- $a Beneš, Petr $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kotlarska 2, 611 37 Brno, Czech Republic. pbenes@sci.muni.cz. $7 xx0208982
- 773 0_
- $w MED00172590 $t Anti-cancer agents in medicinal chemistry $x 1875-5992 $g Roč. 14, č. 10 (2014), s. 1351-1362
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25019627 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20181114095256 $b ABA008
- 999 __
- $a ok $b bmc $g 1092838 $s 915088
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 14 $c 10 $d 1351-1362 $i 1875-5992 $m Anti-cancer agents in medicinal chemistry $n Anticancer Agents Med Chem $x MED00172590
- GRA __
- $a NT13441 $p MZ0
- LZP __
- $a Pubmed-20151005